Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Indisetron

An antiemetic that blocks two serotonin receptors, 5-HT3 and 5-HT4: it was approved in Japan in 2004 to prevent nausea and vomiting caused by cancer chemotherapy. This family brings together the active ingredient and other impurities.

Did you know?The suffix -setron is shared by 5-HT3 receptor antagonists such as ondansetron and granisetron: indisetron, however, also blocks 5-HT4 receptors.

IndisetronGo to the active ingredient →
IndisetronActive ingredientIndisetronCat. No. P-I042-001CAS 141549-75-9

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.